Higher baseline serum magnesium levels are linked to a higher risk for cardiac events in HFmrEF/HFpEF, while empagliflozin treatment shows a lower risk for these events in those with higher magnesium.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/empagliflozin-benefits-patients-heart-failure-high-serum-2026a10001ep?src=rss
Author :
Publish date : 2026-01-15 07:51:00
Copyright for syndicated content belongs to the linked Source.
